Showing results (51-60 of 518) with videos related to
Sort By:
Pageof 52
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 9, 2011
SEOM guidelines for the treatment of malignant pleural mesotheliomaPilar Lianes, Jordi Remon, Isabel Bover, et al.Cancer Treatment Reviews|March 20, 2021
Current treatment and future challenges in ROS1- and ALK-rearranged advanced non-small cell lung cancerJordi Remon, Daniele Pignataro, Silvia Novello, et al.Nature Reviews. Clinical Oncology|July 24, 2023
Immune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challengesGiannis Mountzios, Jordi Remon, Lizza E L Hendriks, et al.Cancer Research|May 3, 2017
Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK-Rearranged Non-Small Cell Lung Cancer PatientsEmma Pailler, Marianne Oulhen, Isabelle Borget, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2016
Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung CancersFrancesco Facchinetti, Yohann Loriot, Mei-Shiue Kuo, et al.European Journal of Cancer (Oxford, England : 1990)|June 10, 2026
Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEXMarco Tagliamento, Marco Bruzzone, Eva Blondeaux, et al.Oncology (Williston Park, N.Y.)|June 24, 2009
Adjuvant or induction cisplatin-based chemotherapy for operable lung cancerBenjamin Besse, Thierry Le ChevalierBulletin Du Cancer|November 27, 2002
[Gemcitabine and breast cancer]Benjamin Besse, Jean-Philippe SpanoTranslational Lung Cancer Research|July 23, 2021
Narrative review of immunotherapy in thymic malignanciesJose Carlos Benitez, Benjamin BesseBulletin Du Cancer|February 5, 2013
[Brain metastases of non small cell lung cancers: systemic treatments]Marie Chaubet-Houdu, Benjamin BessePageof 52